Home > Financial Ratios > SHREE GANESH REMEDIES

SHREE GANESH REMEDIES
Core EBITDA Margin

    Back to All Ratios
SHREE GANESH REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SHREE GANESH REMEDIES
Please provide your vote to see the results

SHREE GANESH REMEDIES Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Margin(%) 25.7825.1427.8118.7424.76

What is the latest Core EBITDA Margin ratio of SHREE GANESH REMEDIES ?

The latest Core EBITDA Margin ratio of SHREE GANESH REMEDIES is 25.78 based on Mar2023 Standalone results.
Year Core EBITDA Margin
Mar202325.78
Mar202225.14
Mar202127.81
Mar202018.74
Mar201924.76

How is Core EBITDA Margin of SHREE GANESH REMEDIES Trending?

Years Core EBITDA Margin % Change
Mar2023 25.78
2.55
Mar2022 25.14
-9.60
Mar2021 27.81
48.40
Mar2020 18.74
-24.31
Mar2019 24.76 -

Other Financial Ratios of SHREE GANESH REMEDIES


Compare Core EBITDA Margin ratio of peers of SHREE GANESH REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES ₹787.5 Cr -1.6% -8.6% 103.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 2.6% -4.7% 54.7% Stock Analytics
CIPLA ₹113,132.0 Cr 4.4% -4.4% 54.7% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 5.8% 17.7% 24.8% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 5.7% 2.7% 29.3% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 0.4% -5.4% 82.7% Stock Analytics


SHREE GANESH REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES

-1.6%

-8.6%

103.8%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses